Celerion - Nebraska

Site Overview

Celerion’s Lincoln, Nebraska facility is a dedicated early-phase clinical research unit specializing in Phase I and clinical pharmacology studies. Established in 1969 and later integrated into Celerion, the site has extensive experience in conducting first-in-human, bioavailability, bioequivalence, and pharmacokinetic/pharmacodynamic (PK/PD) studies. The facility primarily recruits healthy volunteers and supports controlled inpatient and outpatient study designs. With the capacity to enroll approximately 1,600 participants annually, it demonstrates strong operational capability and efficient subject management. The site also benefits from additional infrastructure, including collaborations with the University of Nebraska Innovation Campus and clinical support locations in Bryan Health and Omaha. Equipped with advanced clinical monitoring, safety assessment, and laboratory capabilities, the facility ensures compliance with international regulatory and ethical standards. Overall, the…

Accessibility Features